Holen Sie sich die Stockscreener-App
146.74
0.10%
0.25
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Launches Billion Cell Atlas to Accelerate AI-Driven Drug Development - filmogaz.com
Illumina CEO Sees Big Growth Opportunity in China - marketscreener.com
Illumina Announces Alliance Framework with AstraZeneca, Merck, and Eli Lilly and Company - marketscreener.com
JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery - Pharmaceutical Technology
Illumina Produces Midteens Earnings Growth in 2025, Distancing Itself From the Grail Debacle - Morningstar
Canada Next-Generation Sequencing (NGS) Market Analysis and Forecast, 2025-2035, Featuring Illumina, Oxford Nanopore Technologies, Pacific Bioscience of California, MGI Tech Co., QIAGEN and More - GlobeNewswire
Illumina introduces Billion Cell Atlas, genome-wide genetic perturbation dataset - marketscreener.com
Illumina Billion Cell Atlas to accelerate AI, drug discovery - BioWorld MedTech
Illumina Introduces Illumina Billion Cell Atlas To Accelerate AI Drug Discovery - Nasdaq
Illumina unveils dataset to speed up AI-powered drug discovery - Reuters
Illumina introduces billion cell atlas to accelerate AI and drug discovery - marketscreener.com
Illumina Introduces Genetic Perturbation Dataset to Further AI Drug Discovery - marketscreener.com
Illumina launches billion cell atlas to boost AI-driven drug discovery - Investing.com Australia
Illumina reports 5% revenue growth in Q4 2025, flat for full year - Investing.com Australia
Illumina Preliminary Q4, Annual Results Beat Analysts' View - Nasdaq
(ILMN) Illumina Expects 2025 Revenue About $4.34B, vs. FactSet Est of $4.28B - marketscreener.com
Illumina reports preliminary Q4 revenue of $1.15B - MSN
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery - PR Newswire
Illumina Announces Preliminary Unaudited Financial Results for Q4 and Fiscal Year 2025 - TradingView — Track All Markets
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 - PR Newswire
Illumina launches massive cell atlas to fast-track drug discovery - statnews.com
DNA Methylation Sequencing Market Set to Revolutionize - openPR.com
Illumina and PREMIA partner to expand clinical access to CGP in Asia - ANTARA News
Dr Eric Green named Illumina Chief Medical Officer - Medical Buyer
Illumina, Inc. (ILMN): A Closer Look At Its Growth Potential Amidst Analyst Ratings - DirectorsTalk Interviews
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 - WV News
Illumina names former NIH genomics director as chief medical officer - MedTech Dive
Illumina's New Connected Multiomics Platform Set to Boost Its Stock - The Globe and Mail
How Is The Market Feeling About Illumina Inc? - Benzinga
Cathie Wood’s ARK ETF Buys Intellia, Personalised Stock; Sells Illumina By Investing.com - Investing.com Canada
Cathie Wood’s ARK ETF Buys Intellia, Personalised Stock; Sells Illumina - Investing.com
Illumina Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - sharewise.com
Illumina names former NIH official as medical chief; commercial chief joins Quanterix - Seeking Alpha
Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research® - GlobeNewswire Inc.
Former NIH genomics director Eric Green to join Illumina as CMO - statnews.com
Precision Trading with Illumina Inc. (ILMN) Risk Zones - Stock Traders Daily
Will Illumina Inc. stock split again soon2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Can Illumina Inc. stock sustain revenue growthQuarterly Profit Review & Long-Term Safe Return Strategies - ulpravda.ru
Illumina Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Is Illumina Inc ILU stock a momentum leaderJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - moha.gov.vn
What makes Illumina Inc. (ILU) stock appealing to growth investorsJuly 2025 Recap & Weekly Momentum Picks - ulpravda.ru
Illumina Appoints Dr. Eric Green as Chief Medical Officer - Illumina
Is It Time To Reassess Illumina (ILMN) After Its Recent Share Price Rebound - Yahoo Finance
China Bans Illumina Sequencer Imports as Trade Tensions Rise - MSN
Biochips Market to Reach US$ 38.53 Billion by 2033, Growing at - openPR.com
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
ILMN Stock Price, Forecast & Analysis | ILLUMINA INC (NASDAQ:ILMN) - Chartmill
Illumina launches cloud-based platform for multiomic data analysis By Investing.com - Investing.com Australia
Illumina launches cloud-based platform for multiomic data analysis - Investing.com
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - Illumina
DNA Test Kits Market Booming with Rapid Growth Through 2033 |Devyser, Illumina, Inc., Living DNA Ltd - openPR.com
Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance
1.29%
1.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):